Ambrisentan API is a selective endothelin receptor type-A (ETA) antagonist used in the treatment of pulmonary arterial hypertension (PAH). It works by blocking endothelin-1–mediated vasoconstriction, improving exercise capacity and delaying disease progression. Ambrisentan API is manufactured under GMP-compliant conditions and is suitable for oral tablet formulations.

Ambrisentan API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.